When you look at Vivek Ramaswamy’s early career, his entrance into the chaos that is Republican presidential politics makes at least some sense.
He worked at a hedge fund, QVT Financial, between 2007 and 2014, where he managed its biotech portfolio, which included investments in the firm then run by Martin Shkreli, the man who went to prison after he hiked up the price of a life-saving drug to eye-watering levels.
